Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AEP (AEP) Down 4.7% Since Last Earnings Report: Can It Rebound?
AEP (AEP) Down 4.7% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for American Electric Power (AEP). Shares have lost about 4.7% in that time frame, underperforming the S&P 500.

But investors have to be wondering

Why Is ADM (ADM) Up 7.8% Since Last Earnings Report?
Why Is ADM (ADM) Up 7.8% Since Last Earnings Report?

It has been about a month since the last earnings report for Archer Daniels Midland (ADM). Shares have added about 7.8% in that time frame, outperforming the S&P 500.

Will the recent positive trend

Broadcom Q2 Earnings Surpasses Estimates, Revenues Surge Y/Y
Broadcom Q2 Earnings Surpasses Estimates, Revenues Surge Y/Y

Broadcom AVGO reported second-quarter fiscal 2026 non-GAAP earnings of $2.44 per share, which beat the Zacks Consensus Estimate by 1.67% and rose 54% year over year. Revenues rose 48% year over year

PVH Q1 Earnings Top Estimates, FY26 Sales Outlook Cut, Stock Down
PVH Q1 Earnings Top Estimates, FY26 Sales Outlook Cut, Stock Down

PVH Corporation PVH posted first-quarter fiscal 2026 results, wherein both earnings and revenues topped the Zacks Consensus Estimate. However, the bottom line fell year over year while the top line

Alnylam Bets on AI for Speedy RNAi Drug Discovery and DevelopmentPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Alnylam Bets on AI for Speedy RNAi Drug Discovery and Development

Alnylam Pharmaceuticals ALNY has entered into a strategic collaboration with Inceptive Nucleics aimed at accelerating the discovery and development of next-generation RNA interference (RNAi)

OSIS Gains From Robust Demand, Faces Margin and Timing Headwinds
OSIS Gains From Robust Demand, Faces Margin and Timing Headwinds

OSI Systems OSIS sits at an interesting crossroads. The company is working through a Mexico program transition, yet demand indicators remain strong and management expects cash collection to improve

CRWD Q1 Earnings Surpass Estimates on ARR Strength, AI DemandPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a130cb51-4ded-41be-b600-b83e2078ad65.png
CRWD Q1 Earnings Surpass Estimates on ARR Strength, AI Demand

CrowdStrike CRWD reported non-GAAP earnings per share of $1.10 for the first quarter of fiscal 2027, which surpassed the Zacks Consensus Estimate by 2.8%. The bottom line increased 50.7% on a

The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker
The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker

Key Points

PRU Expands Retirement Market Presence With Fixed Indexed Annuity
PRU Expands Retirement Market Presence With Fixed Indexed Annuity

Prudential Financial, Inc. PRU is expanding its presence in the growing retirement market with the launch of Elevate. This new suite of fixed indexed annuities is aimed at strengthening Prudential's

Jobless Claims Increased More Than Expected
Jobless Claims Increased More Than Expected

Pre-market futures are widely mixed at this hour, following a one-day purge yesterday from all-time highs the day before. Without making too much of this near-term jostling, we can acknowledge that

BFH Stock Trading at a Discount to Industry at 7.96X: Time to Buy?
BFH Stock Trading at a Discount to Industry at 7.96X: Time to Buy?

Bread Financial Holdings, Inc. BFH shares are trading at a discount compared with the Zacks Financial - Miscellaneous Services industry. Its forward price-to-earnings multiple of 7.96X is lower than

Why High Oil Prices Won't Fully Derail VLO's Refining StrengthPhoto, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
Why High Oil Prices Won't Fully Derail VLO's Refining Strength

The Iran-war shock is driving the high crude oil prices, with the price of West Texas Intermediate (“WTI”) crude currently trading at more than the $90-per-barrel mark. The U.S. Energy Information

ONDS' Growing Active Opportunity Pipeline: Multi-Year Growth Secured?
ONDS' Growing Active Opportunity Pipeline: Multi-Year Growth Secured?

Ondas Inc ONDS is witnessing a rapidly expanding opportunity pipeline. On the first-quarter 2026 earnings call, the company disclosed an active pipeline of approximately $4.3 billion in

CIEN Q2 Earnings Beat on AI-Led Networking Demand, FY26 View ElevatedPhoto, wide shot, wide-angle lens,  Telecom equipment supplier, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/3967c11c-b755-4d39-87d0-acc853384c80.png
CIEN Q2 Earnings Beat on AI-Led Networking Demand, FY26 View Elevated

Ciena Corporation CIEN reported fiscal second-quarter 2026 adjusted earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.46. The bottom line surged 290% year over year as

MP Gains 164% in a Year: Should You Buy, Sell or Hold the Stock?
MP Gains 164% in a Year: Should You Buy, Sell or Hold the Stock?

MP Materials’ MP shares have skyrocketed 164.4% in the past year, significantly outperforming the industry’s 60.8% growth, the Zacks Basic Materials sector’s 49% rise and the S&P 500’s gain of 24%.

PVH Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Home appliance manufacturer, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/fb3845ac-e3c6-43ef-86c1-b57ed8c272c4.png
PVH Q1 Earnings Call Highlights

Key Points

Columbus McKinnon Q4 Earnings Call Highlights
Columbus McKinnon Q4 Earnings Call Highlights

Key Points

Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know
Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know

Shares of Kodiak Sciences KOD have risen 34.6% over the past three months against the industry’s 9.5% decline. The rally reflects growing investor confidence in the company's late-stage

ROP's Application Software Unit Keeps Growing: What's Next?Photo, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/ee32e77c-b7d6-424b-91ea-4023f2292688.png
ROP's Application Software Unit Keeps Growing: What's Next?

The Application Software segment remains the cornerstone of Roper Technologies, Inc.’s ROP growth strategy, delivering consistent expansion supported by healthy demand across its Aderant, Deltek

Are Humanoid Robots the Next Trillion-Dollar AI Theme? ETFs in FocusPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/ec495607-1e17-40ee-a41d-7726313a9707.png
Are Humanoid Robots the Next Trillion-Dollar AI Theme? ETFs in Focus

The AI investment story may be entering a new chapter. While the first wave of artificial intelligence was driven by software, cloud computing and semiconductors, the next phase of AI's evolution

TGTX Stock Up on Positive Phase I Data for Subcutaneous Briumvi
TGTX Stock Up on Positive Phase I Data for Subcutaneous Briumvi

Shares of TG Therapeutics TGTX were up 9.5% yesterday after the company announced positive data from a phase I study evaluating the subcutaneous (“SC”) formulation of its sole marketed drug, Briumvi

SYRE Completes Enrollment in SKYWAY Basket Study on SPY072, Stock Up
SYRE Completes Enrollment in SKYWAY Basket Study on SPY072, Stock Up

Shares of Spyre Therapeutics SYRE were up 6.3% yesterday after the company announced that enrollment has been completed for all sub-studies in the SKYWAY basket study evaluating SPY072 (anti-TL1A)

Before the IPO: 4 Companies That Rewarded Investors Who Got In EarlyPhoto, wide shot, wide-angle lens,  Aerospace components, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/3938f51e-9b01-45a9-aed1-ff9d047063fc.png
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early

Key Points

Key Reasons to Buy Atlassian Stock Despite 37% YTD Decline
Key Reasons to Buy Atlassian Stock Despite 37% YTD Decline

Atlassian Corporation TEAM has seen a sharp fall in its stock price, declining 37.4% year to date (YTD), significantly underperforming the Zacks Computer and Technology sector’s growth of 23.5% and

ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data
ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data

ADC Therapeutics ADCT shares plunged 53.4% in after-hours trading on Wednesday despite the company reporting positive top-line results from a late-stage confirmatory study of Zynlonta in combination